betahistine has been researched along with Ataxia in 4 studies
Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the results of the efficacy trial of betahistine (Vestibo) based on the complex clinical/instrumental examination (stabilometric, vestibulometric) in 40 patients with multiple sclerosis of different severity of vestibular and coordination dysfunction." | 7.77 | [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis]. ( Boĭko, AN; Chugunova, MA; Gusev, EI; Kunel'skaia, NL; Popova, NF; Shagaev, AS, 2011) |
| "We present the results of the efficacy trial of betahistine (Vestibo) based on the complex clinical/instrumental examination (stabilometric, vestibulometric) in 40 patients with multiple sclerosis of different severity of vestibular and coordination dysfunction." | 3.77 | [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis]. ( Boĭko, AN; Chugunova, MA; Gusev, EI; Kunel'skaia, NL; Popova, NF; Shagaev, AS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popova, NF | 1 |
| Chugunova, MA | 1 |
| Kunel'skaia, NL | 1 |
| Shagaev, AS | 1 |
| Boĭko, AN | 1 |
| Gusev, EI | 1 |
| Morozova, SV | 1 |
| Zaĭtseva, OV | 1 |
| Prokopenko, SV | 1 |
| Rudnev, VA | 1 |
| Afanas'eva, EV | 1 |
| Abramov, VG | 1 |
| Fujino, A | 1 |
| Tokumasu, K | 1 |
| Okamoto, M | 1 |
| Naganuma, H | 1 |
| Hoshino, I | 1 |
| Arai, M | 1 |
| Yoneda, S | 1 |
1 review available for betahistine and Ataxia
| Article | Year |
|---|---|
[Rehabilitation of patients with peripheral vestibular disorders].
Topics: Ataxia; Betahistine; Combined Modality Therapy; Exercise Therapy; Histamine Agonists; Humans; Vertig | 2004 |
1 trial available for betahistine and Ataxia
| Article | Year |
|---|---|
Vestibular training for acute unilateral vestibular disturbances: its efficacy in comparison with antivertigo drug.
Topics: Adult; Ataxia; Betahistine; Female; Humans; Male; Middle Aged; Severity of Illness Index; Vertigo | 1996 |
2 other studies available for betahistine and Ataxia
| Article | Year |
|---|---|
[Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
Topics: Adult; Ataxia; Betahistine; Female; Histamine Agonists; Humans; Male; Middle Aged; Multiple Sclerosi | 2011 |
[A use of betaserc in ataxic syndromes].
Topics: Aged; Aged, 80 and over; Ataxia; Betahistine; Cerebellar Ataxia; Female; Histamine Agonists; Humans; | 2004 |